MSB 1.40% $1.09 mesoblast limited

https://www.timesofisrael.com/with-low-survival-rate-doctors-see-...

  1. 48 Posts.
    lightbulb Created with Sketch. 107

    https://www.timesofisrael.com/with-low-survival-rate-doctors-see-ventilators-as-gut-wrenching-last-resort/


    this piece that was forwarded from the holy land just shows how desperate everything is when you face ventilation . obviously Israel has first rate medical standards but they have no ammunition to deal with this once it comes down to a ventilator . it just makes one more optimistic that the placebo is not improving and thus remistemcel might well be the answer.

    we also know from all the related trials in adjacent diseases of inflammation like crohns , gvhd , mers and colitis that have cure rates are 70 to 85 percent in spite of what the turkeys at the fda think so that gives us more hope .

    of course remdesivir has just been approved in spite of the fact that the who has said it is ineffective . looks like the bar has been set so low that a limbo dancer would not get under it .politics will play its part though.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.09
Change
0.015(1.40%)
Mkt cap ! $1.238B
Open High Low Value Volume
$1.11 $1.12 $1.08 $11.51M 10.52M

Buyers (Bids)

No. Vol. Price($)
2 17804 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.09 230637 5
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
$1.09
  Change
0.015 ( 1.85 %)
Open High Low Volume
$1.10 $1.12 $1.08 1937390
Last updated 15.59pm 03/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.